IL-9 and IL-9-producing cells in tumor immunity

79Citations
Citations of this article
74Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Interleukin (IL)-9 belongs to the IL-2Rγc chain family and is a multifunctional cytokine that can regulate the function of many kinds of cells. It was originally identified as a growth factor of T cells and mast cells. In previous studies, IL-9 was mainly involved in the development of allergic diseases, autoimmune diseases and parasite infections. Recently, IL-9, as a double-edged sword in the development of cancers, has attracted extensive attention. Since T-helper 9 (Th9) cell-derived IL-9 was verified to play a powerful antitumor role in solid tumors, an increasing number of researchers have started to pay attention to the role of IL-9-skewed CD8+ T (Tc9) cells, mast cells and Vδ2 T cell-derived IL-9 in tumor immunity. Here, we review recent studies on IL-9 and several kinds of IL-9-producing cells in tumor immunity to provide useful insight into tumorigenesis and treatment. [MediaObject not available: See fulltext.] Graphical abstract: [Figure not available: See fulltext.]

Cite

CITATION STYLE

APA

Wan, J., Wu, Y., Ji, X., Huang, L., Cai, W., Su, Z., … Xu, H. (2020, March 30). IL-9 and IL-9-producing cells in tumor immunity. Cell Communication and Signaling. BioMed Central Ltd. https://doi.org/10.1186/s12964-020-00538-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free